Table 1.
Demographic characteristics of 17 patients with severe ulcerative colitis
| Characteristic | Total |
|---|---|
| Male/female sex, no. (%) | 11/6 (65/35) |
| Age, y | |
| Range | 18-78 |
| Mean (SD) | 43 (20) |
| Median (IQR) | 38 (24-62) |
| Clinical type, no. (%) | |
| Initial episode | 11 (65) |
| Relapsing-remitting | 4 (24) |
| Chronic continuous | 2 (12) |
| Extent of ulcerative colitis, no. (%) | |
| Proctitis | 0 (0) |
| Left-sided colitis | 4 (24) |
| Extensive colitis | 13 (76) |
| Disease duration, mo | |
| Range | 1-336 |
| Mean (SD) | 79 (103) |
| Median (IQR) | 36 (11-103) |
| Case referral status, no. (%) | |
| Referred | 9 (53) |
| Nonreferred | 8 (47) |
| Previous status or treatment | |
| Steroid dependent, no. (%) | 2 (12) |
| Previous proctocolectomy, no. (%) | 0 (0) |
| Laboratory test results | |
| C-reactive protein, mg/dL (reference ≤ 0.3 mg/dL) | |
| Mean (SD) | 7.1 (7.2) |
| Median (IQR) | 4.5 (1.5-11.4) |
| Erythrocyte sedimentation rate, mm/h (reference ≤10 mm/h in men, ≤15 mm/h in women) | |
| Mean (SD) | 54 (23) |
| Median (IQR) | 54 (40-66) |
| Positive cytomegalovirus antigenemia, no. (%) | 0/13 (0) |
| Positive immunoassay for Clostridium difficile,a no. (%) | 0/14 (0) |
| Medication during hospitalization, no. (%)b | |
| Oral 5-aminosalicylic acids (5-ASA) | 11 (65) |
| Immunomodulator | 3 (18) |
| Prednisolone (PS) alone or combined with 5-ASA | 2 (12) |
| PS, azathioprine, and 5-ASA | 1 (6) |
| Follow-up period after discharge, y (n = 14) | |
| Mean (SD) | 3.7 (2.8) |
| Median (IQR) | 3.1 (1.3-6.1) |
a C. Diff Quik Chek Complete, TechLab, Blacksburg, VA.
b Percentages do not total to 100 because of rounding.
IQR = interquartile range; SD = standard deviation.